Georgia State professor receives five-year $4.1 million federal grant to develop drug targeting Ebola virus
Can't see this email? View it online
   
  March 15, 2017  
  Ebola Virus  
  The latest Ebola virus news from News Medical  
 Georgia State professor receives five-year $4.1 million federal grant to develop drug targeting Ebola virusGeorgia State professor receives five-year $4.1 million federal grant to develop drug targeting Ebola virus
 
Dr. Christopher Basler, a professor in the Institute for Biomedical Sciences at Georgia State University, director of the university's Center for Microbial Pathogenesis and a Georgia Research Alliance Eminent Scholar in Microbial Pathogenesis, has received a five-year, $4.1 million federal grant to develop a drug targeting Ebola virus.
 
 
 New study examines immune responses to Ebola vaccines at one year after immunizationNew study examines immune responses to Ebola vaccines at one year after immunization
 
Immune responses to Ebola vaccines at one year after vaccination are examined in a new study appearing in the March 14 issue of JAMA.
 
   Study: Investigational Ebola vaccine regimen induced immune response that persisted for one yearStudy: Investigational Ebola vaccine regimen induced immune response that persisted for one year
 
A two-vaccine regimen intended to protect against Ebola virus disease induced an immune response that persisted for approximately one year in healthy adult volunteers, according to results from a Phase 1 clinical trial published in the March 14th issue of the Journal of the American Medical Association.
 
   Researchers quantify consequences of Ebola outbreak on maternal and child health servicesResearchers quantify consequences of Ebola outbreak on maternal and child health services
 
The 2014 Ebola outbreak in West Africa has cost more than 11.000 lives and the health systems in the most affected countries, Guinea, Liberia and Sierra Leone, are still struggling.
 
   Kent researchers identify how Ebola viruses need few mutations to adapt to new host speciesKent researchers identify how Ebola viruses need few mutations to adapt to new host species
 
Kent researchers have identified how few mutations it can take for Ebolaviruses to adapt to affect previously resistant species.
 
 New computer model recommends intervention strategies to mitigate pandemics
 
New computer model recommends intervention strategies to mitigate pandemicsThe 2016 Zika virus outbreak, along with recent outbreaks of SARS, bird flu, H1N1 and Ebola, underscore the importance of being prepared for and responding quickly to infectious diseases. Zika, in particular, poses unique challenges, since its associated birth defects and lack of preventive treatment currently threaten over 60 countries.
 
 
 Rutgers researcher to play key role in federal project aimed at designing TIPs to fight influenza virus
 
Rutgers researcher to play key role in federal project aimed at designing TIPs to fight influenza virusThey're called TIPs and their task would be to infiltrate and outcompete influenza, HIV, Ebola and other viruses.